iSpecimen Inc
NASDAQ:ISPC
Relative Value
The Relative Value of one ISPC stock under the Base Case scenario is 1.701 USD. Compared to the current market price of 0.263 USD, iSpecimen Inc is Undervalued by 85%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ISPC Competitors Multiples
iSpecimen Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
iSpecimen Inc
NASDAQ:ISPC
|
2.4m USD | 0.2 | -0.2 | 0.3 | 0.2 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.8B USD | 13.9 | 62.4 | 62.3 | 67 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.9B AUD | 81.1 | 170.1 | 117 | 117 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7.4B USD | 11.8 | -349 | -184.9 | -171.9 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 4.8 | 24.1 | 12.5 | 14.1 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.6 | 32.6 | 21.8 | 23.2 | ||
SE |
Sectra AB
STO:SECT B
|
42.6B SEK | 26 | 100.4 | -66.1 | -66.1 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.7 | 25.6 | 272.8 | ||
US |
Certara Inc
NASDAQ:CERT
|
2.8B USD | 7.9 | -50.8 | 46 | 461.6 |